Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:53:54 EDT Wed 25 Jun 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

V:NRX - NurExone Biologic Inc. - https://www.nurexone.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NRX - V  1.00.66·0.696.00.68-0.01-1.455.938380.68  0.72  0.670.83  0.52Jun 24Jun 2015 min RT 2¢
TSX-V - V1.00.66·0.696.00.68-0.01-1.442.529210.68  0.72  0.680.83  0.52Jun 2415 min
NEO ATS - U 0.70+0.011.411.0780.71  0.71  0.70Jun 2415 min
Chi-X - X 0.67-0.02-2.90.5010.67  0.67  0.67Jun 2415 min
CX2 - H 0.70+0.011.40.5010.70  0.70  0.70Jun 2415 min
CXD - D 0.690.402    Jun 2315 min
TriAct - M 0.691.015    15 min

Recent Trades - Last 10 of 38
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-20 10:16C:NRX0.67News ReleaseNurexone Biologic joins HealthTech Hub program
2025-06-04 19:38C:NRX0.71News ReleaseNurexone presents at conference, to hold AGM June 18
2025-05-30 18:01C:NRX0.68News ReleaseNurexone Biologic adviser to present at ASIA meeting
2025-05-27 08:59C:NRX0.66News ReleaseNurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update
2025-05-27 08:42C:NRX0.66SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-27 08:42C:NRX0.66SEDAR Interim MD & ASEDAR Interim MD & A
2025-05-09 03:27C:NRX0.66News ReleaseNurexone's ExoPTEN data presented at annual meeting
2025-05-02 16:05C:NRX0.705News ReleaseNurExone Expands European Engagement with Investor Events in Germany and Switzerland
2025-04-24 16:55C:NRX0.64Private PlacementNurexone Biologic 3,543,238-share private placement
2025-04-24 16:15C:NRX0.64News ReleaseNurExone to Showcase Breakthrough in Facial Nerve Regeneration at ISEV 2025
2025-04-22 20:18C:NRX0.65News ReleaseNurexone appoints Licht as CEO of Exo-Top
2025-04-09 17:16C:NRX0.68SEDAR MD & ASEDAR MD & A
2025-04-09 17:15C:NRX0.68News ReleaseNurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
2025-04-09 17:04C:NRX0.68SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-04-04 16:12C:NRX0.67News ReleaseNurexone closes $2.3-million private placement
2025-03-14 16:42C:NRX0.65News ReleaseNurexone completes preclinical study for ExoPTEN
2025-02-27 16:03C:NRX0.57News ReleaseNurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of NurExone Ophthalmology Project, to Receive Lifetime Achievement Award
2025-02-14 16:03C:NRX0.61News ReleaseNurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
2025-02-05 18:29C:NRX0.58News ReleaseNurexone Biologic forms U.S.-based subsidiary
2025-02-03 17:16C:NRX0.58Private PlacementNurexone Biologic 856,996-share private placement